FENTANYL Sublingual (AbstralĀ®)

Clinical Indication

Breakthrough cancer pain in patients already on opioids. Palliative care in line with guidance


Conditional on recommendation from palliative care team.
See:Ā Palliative care – drugs for use only after specialist recommendation

Date of classification

June 2015


Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.